Bravo E L
Cleveland Clinic Research Institute, Ohio.
Hypertension. 1988 Mar;11(3 Pt 2):II7-10. doi: 10.1161/01.hyp.11.3_pt_2.ii7.
Phenylpropanolamine is a sympathomimetic amine that shares structural similarities with amphetamine and ephedrine. It increases blood pressure primarily by increasing peripheral vascular resistance. This effect is the result of alpha-adrenergic agonist activity largely from both direct stimulation of adrenergic receptors and release of neuronal norepinephrine. As such, it has the potential to interact with other drugs to produce toxic reactions, especially in treated hypertensive patients. Complications have occurred with single oral doses that suggest some normal subjects may be more sensitive to the drug than others. The incidence of serious complications in the general population is small but could be much higher in susceptible individuals (e.g., cardiomyopathic and hypertensive patients). The availability of high-dose phenylpropanolamine-containing preparations without medical supervision is potentially dangerous, and certain restrictions should be imposed on such preparations.
苯丙醇胺是一种拟交感神经胺,其结构与苯丙胺和麻黄碱相似。它主要通过增加外周血管阻力来升高血压。这种作用主要是由于α-肾上腺素能激动剂的活性,这源于对肾上腺素能受体的直接刺激以及神经元去甲肾上腺素的释放。因此,它有可能与其他药物相互作用产生毒性反应,尤其是在接受治疗的高血压患者中。单次口服剂量就已出现并发症,这表明一些正常受试者可能比其他人对该药物更敏感。普通人群中严重并发症的发生率较低,但在易感个体(如心肌病患者和高血压患者)中可能会高得多。在没有医学监督的情况下可获得高剂量含苯丙醇胺制剂存在潜在危险,应对此类制剂加以某些限制。